beta2-GP1 Ab IgM ELISA Kit

Produktnummer ABIN996882

Produktdetails beta2-GP1 Ab IgM ELISA Kit

Target: beta2-GP1 Ab IgM (Beta2-Glycoprotein 1 Antibody IgM (beta2-GP1 Ab IgM))

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Competition ELISA

Applikation: ELISA

Verwendungszweck: ß2GP1 IgM Enzyme-linked Immunosorbent Assay (ELISA) is intended for the detection and semiquantitative determination of IgM antibodies to ß2GP1 in human sera or plasma.

Analytische Methode: Semi-Quantitative

Spezifität: 85.4 %

Anwendungsinformationen

Probenmenge: 5 μL

Testdauer: 1 - 2 h

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C

Haltbarkeit: 12 months

Details zu beta2-GP1 Ab IgM

Target: beta2-GP1 Ab IgM (Beta2-Glycoprotein 1 Antibody IgM (beta2-GP1 Ab IgM))

Abstract: beta2-GP1 Ab IgM Produkte

Substanzklasse: Antibody

Hintergrund: Cardiolipin autoantibodies (ACA) are described for various autoimmune diseases. The presence of anti-cardiolipin antibodies in systemic lupus erythematosus (SLE) can be related to the development of thrombocytopenia, in gynaecology they are supposed to cause intrauterine death or recurrent abortion. Furthermore, anti-cardiolipin antibodies have been found in some non-thrombotic neurological disorders like cerebrovascular insufficiency, cerebral ischemia or chorea and in myocardial infarction. Recent studies have shown that a 50kD serum cofactor is required for anticardiolipin antibodies, to bind to cardiolipin which has been coated onto plastic plates. The cofactor has been identified as beta 2 -glycoprotein 1 also termed apolipoprotein H. beta 2 GP1 has been known as an in vitro inhibitor of the intrinsic blood coagulation pathway, ADP-dependent aggregation, and prothrombinase activity of activated platelets. It has become apparent that anticardiolipin antibody from patients with anti-phospholipid syndrome (APS) recognize a modified beta 2 GP1 structure and not cardiolipin, native beta 2 GP1 or an epitope structurally defined by both cardiolipin and beta 2 GP1.

Galli et al. and Viard, et al. reported that anti-cardiolipin antibody derived from SLE and APS were directed to the beta 2 GP1 molecule coated on polystyrene plates. Koike and Matsuura showed conclusively that beta2GP1 is indeed the antigen to which many anticardiolipin antibody patients are actually binding and furthermore showed that the phospholipid merely serves to link the beta 2 GP1 to the solid phase. beta 2 GP1 autoantibodies are found in the immunoglobulin classes IgG, IgM and IgA. The determination of IgM antibodies is a valuable indicator in the diagnosis of beginning autoimmune disease, whereas IgG and/or IgA antibodies will be found in progressive stages of manifested autoimmune disorders. IgA antibodies are often associated with IgG antibodies. The determination of IgA antibodies seems to have a greater validity in thrombosis and fetal loss.. Indications for determination of anti beta 2 GP1 antibodies are: SLE, Thrombosis, Thrombocytopenia, Cerebral Ischemia, Chorea, Epilepsy, Recurrent Abortion and Intrauterine Death.